Lipid-Nanoparticle Based Genomic Medicines Market Share To Demonstrate Enormous Rise Over Estimated Forecast Timeline – iSay Research Study
The Global Lipid-Nanoparticle-Based Genomic Medicines Market was valued at USD 16.23 Billion in 2022 and is projected to reach USD 36.50 Billion by 2032, registering a CAGR of 8.40 % for the forecast period 2023-2032. The Lipid-Nanoparticle Based Genomic Medicines Market size study shifts its attention to in-depth business challenges, defined investment opportunities, market share...
0 Comentários 0 Compartilhamentos 176 Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado